RedLeaf Biologics Inc. – Trademark Portfolio
Entity Type: 03
RedLeaf Biologics Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include 3-DAXIN and REDAXIN. The owner is based in Nicholasville, KY.
1784 Delaney Ferry Rd.
Nicholasville, KY 40356
Showing of trademarks Trademarks
Trademark Classifications
RedLeaf Biologics Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does RedLeaf Biologics Inc. have?
RedLeaf Biologics Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 8 abandoned.
What trademark classes does RedLeaf Biologics Inc. file in?
RedLeaf Biologics Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 30 (Staple Foods), Class 2 (Paints). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are RedLeaf Biologics Inc.'s most well-known trademarks?
RedLeaf Biologics Inc.'s registered trademark portfolio includes well-known marks such as 3-DAXIN and REDAXIN. These are among 2 currently registered trademarks in the portfolio.
What is RedLeaf Biologics Inc.'s trademark registration success rate?
RedLeaf Biologics Inc. has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 2 applications are pending review.